Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging
clinical decision making. In this review key clinical and pathological issues and informative …

Simple Summary Lung carcinoids are divided into typical and atypical. Most tumors are slow-
growing yet have malignant potential, which is more common in patients harboring atypical …

Background Atypical carcinoid (AC) of the lung is a rare form of thoracic malignancy. The
limited knowledge of its biology and outcome stems largely from small, single institution …

Neuroendocrine neoplasms of the lung represent about 20% to 30% of all neuroendocrine
tumors. On the basis of clinical and pathologic characteristics, 2 different categories of …

Generally, patients with stage I-IIIa (TNM) pulmonary carcinoid disease have a favourable
prognosis after curative resection. Yet, distant recurrence of disease after curative surgery …

Neuroendocrine tumors of the lung are classified into low-grade typical and intermediate-
grade atypical carcinoids, and high-grade poorly differentiated neuroendocrine carcinomas …

Neuroendocrine tumors (NET) of the lung represent approximately 25% of all primary lung
tumors and can be classified as low grade (typical carcinoids), intermediate grade (atypical …

Background Histological subdivision into typical (TC) and atypical (AC) is crucial for
treatment and prognosis of lung carcinoids but can be also very challenging, even for …

Objective Neuroendocrine tumors of the lung are currently staged with the 7th edition TNM
non–small cell lung cancer staging system. This decision, based on data analysis without …

Pulmonary neuroendocrine tumors represent a morphologic spectrum of tumors from the
well-differentiated typical carcinoid tumor, to the intermediate-grade atypical carcinoid tumor …